Philadelphia, Pennsylvania--(Newsfile Corp. - February 12, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Masonite International Corporation (NYSE: DOOR) ("Masonite" or the "Company") on behalf of investors who sold Masonite common stock during the period from June 5, 2023 through February 8, 2024 (the "Class Period").Investor Deadline: Investors who sold Masonite securities during the Class Period may, no later than April 7, 2026, seek ...

Group 1 - A class action lawsuit has been filed against uniQure N.V. on behalf of investors who purchased shares between September 24, 2025, and October 31, 2025 [1] - The lawsuit alleges that uniQure misled investors regarding the likelihood of FDA approval for its leading drug candidate, AMT-130, by failing to disclose that the pivotal study design was not fully approved by the FDA [1] - Following the announcement on November 3, 2025, regarding FDA feedback, uniQure's share price dropped by $33.40, or over 49%, from $67.69 to $34.29 [1] Group 2 - Robbins LLP is also investigating a class action lawsuit against POMDoctor Ltd. for investors who acquired securities between October 9, 2025, and December 11, 2025 [1] - Another class action has been filed against Inovio Pharmaceuticals, Inc. for investors who purchased securities between October 10, 2023, and December 26, 2025 [1] - A class action lawsuit has been initiated against Masonite International Corporation for sellers of common stock between June 5, 2023, and February 8, 2024 [1]

Core Viewpoint - The Masonite International Corporation is facing a class action lawsuit for allegedly failing to disclose acquisition offers from Owens Corning while repurchasing its own stock, potentially misleading investors during the Class Period from June 5, 2023, to February 8, 2024 [1][3]. Company Overview - Masonite International Corporation is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for both residential and non-residential building construction markets, including new construction and renovation sectors [2]. Legal Allegations - The lawsuit claims that Masonite repurchased its stock while knowing that it had received multiple formal acquisition offers from Owens Corning at prices significantly above the market value, which constituted a failure to disclose critical information to investors [3]. Class Action Details - Investors who sold Masonite common stock during the Class Period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [5]. - The lead plaintiff will have the authority to select a law firm to litigate the case and does not need to be the lead plaintiff to share in any potential recovery [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone, marking its fourth 1 ranking in the past five years [6].